Global Oncology Market to Grow at a Robust CAGR Through 2025 on Account of Application in Cancer Treatment
The global oncology biosimilars market is likely to grow at a robust pace of nearly 28% through 2025 on account of growing use in treatment and management of cancers. As the pharmaceutical industry focuses on developing affordable and effective drugs, it is highly likely that oncology biosimilars will witness a push. These factors will combine to fuel the global market during the review period 2017-2025 according to a new study added to the database of Market Research Reports Search Engine...
View full press release